Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White House said on Thursday. The biotech company will also offer the first hearing-loss gene therapy for free to eligible U.S. patients following regulatory approval of the product earlier Thursday. Regeneron is the latest in…
